|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cancer Genome Atlas Network, .
Comprehensive molecular characterization of human colon and rectal
cancer. Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koveitypour Z, Panahi F, Vakilian M,
Peymani M, Seyed Forootan F, Nasr Esfahani MH and Ghaedi K:
Signaling pathways involved in colorectal cancer progression. Cell
Biosci. 9:972019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wongfieng W, Jumnainsong A, Chamgramol Y,
Sripa B and Leelayuwat C: 5′-UTR and 3′-UTR regulation of MICB
expression in human cancer cells by novel microRNAs. Genes (Basel).
8:2132017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gebert LF and MacRae IJ: Regulation of
microRNA function in animals. Nat Rev Mol Cell Biol. 20:21–37.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi
S, Xie H, Peng X, Yin W, Tao Y and Wang X: miRNA-based biomarkers,
therapies, and resistance in cancer. Int J Biol Sci. 16:2628–2647.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu G and Li B: Role of miRNA in
transformation from normal tissue to colorectal adenoma and cancer.
J Cancer Res Ther. 15:278–285. 2019.PubMed/NCBI
|
|
12
|
Pidíkova P, Reis R and Herichova I: miRNA
clusters with down-regulated expression in human colorectal cancer
and their regulation. Int J Mol Sci. 21:46332020. View Article : Google Scholar
|
|
13
|
Bartels CL and Tsongalis GJ: MicroRNAs:
Novel biomarkers for human cancer. Ann Biol Clin (Paris).
68:263–272. 2010.(Artcle in French). PubMed/NCBI
|
|
14
|
Santos P and Almeida F: Role of Exosomal
miRNAs and the tumor microenvironment in drug resistance. Cells.
9:14502020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren A, Dong Y, Tsoi H and Yu J: Detection
of miRNA as non-invasive biomarkers of colorectal cancer. Int J Mol
Sci. 16:2810–2823. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Michael MZ, Connor SM, van Holst Pellekaan
NG, Young GP and James RJ: Reduced accumulation of specific
microRNAs in colorectal neoplasia. Mol Cancer Res. 1:882–891.
2003.PubMed/NCBI
|
|
17
|
Nagy ZB, Wichmann B, Kalmár A, Galamb O,
Barták BK, Spisák S, Tulassay Z and Molnár B: Colorectal adenoma
and carcinoma specific miRNA profiles in biopsy and their
expression in plasma specimens. Clin Epigenetics. 9:222017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Long J, He Q, Yin Y, Lei X, Li Z and Zhu
W: The effect of miRNA and autophagy on colorectal cancer. Cell
Prolif. 53:e129002020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weiser MR: AJCC 8th edition: Colorectal
cancer. Ann Surg Oncol. 25:1454–1455. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Z, Wu L, Wang A, Tang W, Zhao Y, Zhao
H and Teschendorff AE: dbDEMC 2.0: Updated database of
differentially expressed miRNAs in human cancers. Nucleic Acids
Res. 45:D812–D818. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie B, Ding Q, Han H and Wu D: miRCancer:
A microRNA-cancer association database constructed by text mining
on literature. Bioinformatics. 29:638–644. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hulsen T, de Vlieg J and Alkema W:
BioVenn-a web application for the comparison and visualization of
biological lists using area-proportional Venn diagrams. BMC
Genomics. 9:4882008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang JX, Song W, Chen ZH, Wei JH, Liao
YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, et al: Prognostic and
predictive value of a microRNA signature in stage II colon cancer:
A microRNA expression analysis. Lancet Oncol. 14:1295–1306. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mansoori B, Mohammadi A, Naghizadeh S,
Gjerstorff M, Shanehbandi D, Shirjang S, Najafi S, Holmskov U,
Khaze V, Duijf PH and Baradaran B: miR-330 suppresses EMT and
induces apoptosis by downregulating HMGA2 in human colorectal
cancer. J Cell Physiol. 235:920–931. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Anandappa G, Lampis A, Cunningham D, Khan
KH, Kouvelakis K, Vlachogiannis G, Hedayat S, Tunariu N, Rao S,
Watkins D, et al: miR-31-3p expression and benefit from anti-egfr
inhibitors in metastatic colorectal cancer patients enrolled in the
prospective phase II PROSPECT-C Trial. Clin Cancer Res.
25:3830–3838. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shrestha A, Mukhametshina RT, Taghizadeh
S, Vásquez- Pacheco E, Cabrera-Fuentes H, Rizvanov A, Mari B,
Carraro G and Bellusci S: MicroRNA-142 is a multifaceted regulator
in organogenesis, homeostasis, and disease. Dev Dyn. 246:285–290.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lawson J, Dickman C, Towle R, Jabalee J,
Javer A and Garnis C: Extracellular vesicle secretion of miR-142-3p
from lung adenocarcinoma cells induces tumor promoting changes in
the stroma through cell-cell communication. Mol Carcinog.
58:376–387. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mansoori B, Mohammadi A, Ghasabi M,
Shirjang S, Dehghan R, Montazeri V, Holmskov U, Kazemi T, Duijf P,
Gjerstorff M and Baradaran B: miR-142-3p as tumor suppressor miRNA
in the regulation of tumorigenicity, invasion and migration of
human breast cancer by targeting Bach-1 expression. J Cell Physiol.
234:9816–9825. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Y, Cao Z, Wang L, Liu S and Cai J:
Downregulation of microRNA-142-3p and its tumor suppressor role in
gastric cancer. Oncol Lett. 15:8172–8180. 2018.PubMed/NCBI
|
|
37
|
Gao W, Pang D and Yu S: Serum level of
miR-142-3p predicts prognostic outcome for colorectal cancer
following curative resection. J Int Med Res. 47:2116–2125. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shen WW, Zeng Z, Zhu WX and Fu GH:
MiR-142-3p functions as a tumor suppressor by targeting CD133,
ABCG2, and Lgr5 in colon cancer cells. J Mol Med (Berl).
91:989–1000. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ghanbari R, Mosakhani N, Asadi J, Nouraee
N, Mowla SJ, Yazdani Y, Mohamadkhani A, Poustchi H, Knuutila S and
Malekzadeh R: Downregulation of plasma MiR-142-3p and MiR-26a-5p in
patients With colorectal carcinoma. Iran J Cancer Prev.
8:e23292015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xu T, He BS, Pan B, Pan YQ, Sun HL, Liu
XX, Xu XN, Chen XX, Zeng KX, Xu M and Wang SK: MiR-142-3p functions
as a tumor suppressor by targeting RAC1/PAK1 pathway in breast
cancer. J Cell Physiol. 235:4928–4940. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Peng D, Dong J, Zhao Y, Peng X, Tang J,
Chen X, Wang L, Hu DN, Reinach PS, Qu J and Yan K: miR-142-3p
suppresses uveal melanoma by targeting CDC25C, TGFβR1, GNAQ, WASL,
and RAC1. Cancer Manag Res. 11:4729–4742. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li WQ, Zhao WC, Xin J, Niu TL, Chao YF,
Zhou P, Zheng MH and Xu B: MicroRNA-142-3p suppresses cell
proliferation and migration in bladder cancer via Rac1. J Biol
Regul Homeost Agents. Feb 28–2020.(Epub ahead of print).
|
|
43
|
Liu J, Li W and Wang S, Wu Y, Li Z, Wang
W, Liu R, Ou J, Zhang C and Wang S: MiR-142-3p attenuates the
migration of CD4+ T cells through regulating actin
cytoskeleton via RAC1 and ROCK2 in arteriosclerosis obliterans.
PLoS One. 9:e955142014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sahajpal N, Kowluru A and Kowluru RA: The
regulatory role of rac1, a small molecular weight GTPase, in the
development of diabetic retinopathy. J Clin Med. 8:9652019.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nguyen LK, Kholodenko BN and von
Kriegsheim A: Rac1 and RhoA: Networks, loops and bistability. Small
GTPases. 9:316–321. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
De P, Aske JC and Dey N: RAC1 Takes the
lead in solid tumors. Cells. 8:3822019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kotelevets L and Chastre E: Rac1
signaling: From intestinal homeostasis to colorectal cancer
metastasis. Cancers (Basel). 12:6652020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhou K, Rao J, Zhou ZH, Yao XH, Wu F, Yang
J, Yang L, Zhang X, Cui YH, Bian XW, et al: RAC1-GTP promotes
epithelial-mesenchymal transition and invasion of colorectal cancer
by activation of STAT3. Lab Invest. 98:989–998. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gao X, Xu W, Lu T, Zhou J, Ge X and Hua D:
MicroRNA-142-3p promotes cellular invasion of colorectal cancer
cells by activation of RAC1. Technol Cancer Res Treat. Jan
1–2018.(Epub ahead of print). View Article : Google Scholar
|
|
50
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: MicroRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang X, Zuo X, Yang B, Li Z, Xue Y, Zhou
Y, Huang J, Zhao X, Zhou J, Yan Y, et al: MicroRNA directly
enhances mitochondrial translation during muscle differentiation.
Cell. 158:607–619. 2014. View Article : Google Scholar : PubMed/NCBI
|
